News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
193,239 Results
Type
Article (6207)
Company Profile (20)
Press Release (187011)
Multimedia
Podcasts (6)
Webinars (2)
Section
Business (50706)
Career Advice (70)
Deals (8067)
Drug Delivery (15)
Drug Development (26939)
Employer Resources (7)
FDA (4936)
Job Trends (3892)
News (85118)
Policy (8690)
Tag
2026 Best Places to Work (2)
2027 BioCapital Standard (1)
40 Under 40 (2)
Academia (698)
Accelerated approval (34)
ADA (27)
Adcomms (1)
Allergies (74)
Alliances (11565)
ALS (132)
Alzheimer's disease (562)
Antibody-drug conjugate (ADC) (317)
Approvals (5642)
Artificial intelligence (430)
ASCO (158)
Autoimmune disease (191)
Automation (39)
Bankruptcy (66)
Belgium (18)
Best Places to Work (3576)
BIO (27)
Biologics (42)
Biosimilars (138)
BioSpace Insights (10)
Biotechnology (12)
Bispecific (27)
Bladder cancer (185)
Brain cancer (37)
Breast cancer (491)
Cancer (3883)
Cardiovascular disease (301)
Career advice (69)
Career pathing (1)
CAR-T (129)
CDC (9)
CDMO (50)
Celiac Disease (1)
Cell therapy (404)
Cervical cancer (32)
Clinical research (26411)
Collaboration (1243)
Commercialization (26)
Compensation (709)
Complete response letters (30)
COVID-19 (1968)
CRISPR (68)
CRO (2)
C-suite (662)
Cystic fibrosis (56)
Data (5902)
Decentralized trials (1)
Denatured (1)
Depression (87)
Dermatology (122)
Diabetes (285)
Diagnostics (2549)
Digital health (30)
Diversity (3)
Diversity, equity & inclusion (2)
Drug discovery (193)
Drug pricing (33)
Drug shortages (5)
Duchenne muscular dystrophy (135)
Earnings (24393)
Editorial (4)
Employer branding (1)
Employer resources (6)
ESMO (251)
Events (32001)
Executive appointments (603)
Eye disease (14)
FDA (7460)
Fibrodysplasia Ossificans Progressiva (12)
Fragile X (3)
Friedreich's ataxia (10)
Frontotemporal dementia (16)
Funding (921)
Gene editing (115)
Generative AI (27)
Gene therapy (322)
GLP-1 (287)
Government (1329)
Grass and pollen (3)
Guidances (217)
Healthcare (5125)
Hematology (117)
HIV (81)
Huntington's disease (37)
Idiopathic pulmonary fibrosis (7)
IgA nephropathy (60)
Immunology and inflammation (59)
Immuno-oncology (53)
Indications (164)
Infectious disease (2184)
Inflammatory bowel disease (73)
Inflation Reduction Act (5)
Influenza (102)
Intellectual property (128)
Interviews (7)
IPO (3655)
IRA (7)
Job creations (607)
Job search strategy (65)
JPM (5)
Kidney cancer (17)
Kidney disease (72)
Labor market (6)
Layoffs (65)
Leadership (1)
Legal (1773)
Licensing (55)
Liver cancer (46)
Longevity (17)
Lung cancer (584)
Lung diease (11)
Lymphoma (329)
Machine learning (35)
Management (1)
Manufacturing (515)
Marketing (21)
MASH (117)
Medical affairs (2)
Medical device (3434)
Medtech (3536)
Mergers & acquisitions (5150)
Metabolic disorders (609)
mRNA (108)
Multiple sclerosis (112)
Multispecific (2)
NASH (5)
Netherlands (26)
Neurodegenerative disease (204)
Neuropsychiatric disorders (37)
Neuroscience (1396)
Neurotech (2)
NextGen: Class of 2026 (823)
Non-profit (1096)
Now hiring (4)
Obesity (190)
Opinion (31)
Ovarian cancer (165)
Pain (145)
Pancreatic cancer (197)
Parkinson's disease (153)
Partnered (7)
Patents (250)
Patient advocacy (4)
Patient recruitment (441)
Patient selection (44)
Peanut (20)
People (13254)
Peptides (21)
Pharmaceutical (2)
Pharmacy benefit managers (9)
Phase 1 (7283)
Phase 2 (11194)
Phase 3 (10061)
Pipeline (6958)
Policy (28)
Postmarket research (1004)
Preclinical (2773)
Press Release (56)
Prostate cancer (211)
Psychedelics (12)
Radioligand (1)
Radiopharmaceuticals (134)
Rare diseases (552)
Real estate (1239)
Recruiting (4)
Regenerative medicine (14)
Regulatory (8565)
Reports (13)
Research institute (784)
Resumes & cover letters (7)
Rett syndrome (42)
RNA editing (14)
RSV (52)
Schizophrenia (79)
Series A (146)
Series B (115)
Service/supplier (2)
Sickle cell disease (61)
Special edition (1)
Spinal muscular atrophy (80)
Sponsored (10)
Startups (525)
State (1)
Stem cells (5)
Stomach cancer (1)
Substance use disorders (10)
Supply chain (57)
Switzerland (8)
Tariffs (9)
The Weekly (5)
Vaccines (545)
Venture capital (25)
Weight loss (74)
Wet AMD (3)
Women's health (65)
Date
Today (87)
Last 7 days (400)
Last 30 days (1733)
Last 365 days (13782)
2026 (12420)
2025 (13864)
2024 (11196)
2023 (10758)
2022 (14890)
2021 (16187)
2020 (16007)
2019 (10350)
2018 (7671)
2017 (7379)
2016 (6982)
2015 (8487)
2014 (6193)
2013 (5120)
2012 (5845)
2011 (6105)
2010 (5993)
Location
Africa (116)
Alabama (35)
Alaska (1)
Arizona (70)
Arkansas (6)
Asia (9273)
Australia (1115)
California (6849)
Canada (1714)
China (604)
Colorado (332)
Connecticut (381)
Delaware (345)
Europe (23005)
Florida (740)
Georgia (210)
Hawaii (4)
Idaho (8)
Illinois (653)
India (67)
Indiana (192)
Iowa (17)
Japan (479)
Kansas (18)
Kentucky (14)
Louisiana (29)
Maine (9)
Maryland (550)
Massachusetts (5091)
Michigan (114)
Minnesota (262)
Mississippi (1)
Missouri (66)
Montana (2)
Nebraska (3)
Nevada (101)
New Hampshire (91)
New Jersey (4299)
New Mexico (26)
New York (2162)
North Carolina (2051)
North Dakota (14)
Northern California (3679)
Ohio (186)
Oklahoma (10)
Oregon (17)
Pennsylvania (983)
Puerto Rico (7)
Rhode Island (18)
South America (237)
South Carolina (10)
South Dakota (1)
Southern California (2539)
Tennessee (96)
Texas (1136)
United States (27171)
Utah (102)
Virginia (419)
Washington D.C. (19)
Washington State (472)
West Virginia (3)
Wisconsin (134)
Wyoming (3)
193,239 Results for "qiagen n v".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
QIAGEN N.V. to Release Results for Q2 2026 and Hold Webcast
July 16, 2026
·
1 min read
Press Releases
Vivoryon Therapeutics N.V. Reports Q3 2026 Financial Results and Provides Business Update
November 5, 2026
·
9 min read
Press Releases
QIAGEN Reports Full Q3 2026 Results
November 5, 2026
·
13 min read
Press Releases
Vivoryon Therapeutics N.V. Reports Outcome of 2026 Annual General Meeting
September 29, 2026
·
3 min read
Press Releases
QIAGEN Shareholders Overwhelmingly Approve Jonathan M. Pratt as Managing Director
November 8, 2026
·
2 min read
Press Releases
Vivoryon Therapeutics N.V. to Report Q3 2026 Financial Results on November 5, 2026
October 30, 2026
·
3 min read
Press Releases
QIAGEN N.V. to Release Results for Q4 2025 and Hold Webcast
January 20, 2026
·
1 min read
Press Releases
QIAGEN Expands AI-Powered Bioinformatics for Research and Drug Discovery
October 7, 2026
·
4 min read
Press Releases
QIAGEN Launches QIAmini to Automate Small-Batch Sample Preparation
September 24, 2026
·
3 min read
Press Releases
QIAGEN Convenes Global Tuberculosis Experts as New Pressures Challenge Progress Against Tuberculosis
October 14, 2026
·
5 min read
1 of 19,324
Next